Targeting the Expression of Platelet-Derived Growth Factor Receptor by Reactive Stroma Inhibits Growth and Metastasis of Human Colon Carcinoma
- 31 December 2006
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 169 (6), 2054-2065
- https://doi.org/10.2353/ajpath.2006.060653
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Simultaneous Inhibition of EGFR, VEGFR, and Platelet-Derived Growth Factor Receptor Signaling Combined with Gemcitabine Produces Therapy of Human Pancreatic Carcinoma and Prolongs Survival in an Orthotopic Nude Mouse ModelCancer Research, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Desmin Ensheathment Ratio as an Indicator of Vessel Stability: Evidence in Normal Development and in Retinopathy of PrematurityThe American Journal of Pathology, 2004
- Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?Lung Cancer, 2004
- Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanismsThe FASEB Journal, 2003
- Endothelial-pericyte interactions in angiogenesisCell and tissue research, 2003
- In vivo and in vitro Interactions between Human Colon Carcinoma Cells and Hepatic Stellate CellsJapanese Journal of Cancer Research, 2000
- The Hallmarks of CancerCell, 2000
- The Tumor-Promoting Effect of Wounding: A Possible Role for TGF-β-lnduced Stromal AlterationsCritical Reviews™ in Oncogenesis, 1994
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986